Bioinformatics Analysis of Livestock Genomics
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM) is soliciting quotations for Bioinformatics Analysis of Livestock Genomics. This Total Small Business Set-Aside opportunity seeks external support to validate genomic variants in CRISPR/Cas9 gene-edited swine samples and generate breed-specific variant call files (VCFs) for cattle, chicken, and swine. CVM requires this support due to internal personnel being allocated to other high-priority projects. Quotes are due by June 29, 2026.
Scope of Work
The contractor will provide specialized bioinformatics services, including:
- Visual validation of genomic variants from whole genome sequencing (WGS) data of CRISPR/Cas9 gene-edited swine samples.
- Generation of CRISPRme-ready input files, specifically breed-specific VCFs for cattle, chicken, and swine.
- Deliverables include validated variant results, breed-specific VCFs, all associated scripts and workflows, and a comprehensive final report. All work must be performed within the United States.
Contract & Timeline
- Contract Type: Firm Fixed Price Purchase Order
- Period of Performance: July 15, 2026, to July 14, 2027 (one-year base period, no option years)
- Set-Aside: Total Small Business Set-Aside (FAR 19.5)
- Questions Due: June 18, 2026, by 3:00 PM ET
- Quotes Due: June 29, 2026, by 3:00 PM ET
- Published Date: June 11, 2026
Evaluation
Award will be made based on a Firm Fixed Price contract using a Trade-Off Process, prioritizing a combination of technically superior and low-risk proposals. Evaluation factors include:
- Technical Approach
- Facilities
- Price/Cost
Additional Notes
- All data transfer and communication must be conducted via precisionFDA.
- Contractors must comply with all applicable Federal Acquisition Regulation (FAR) and HHS Acquisition Regulation (HHSAR) clauses.
- No travel is required for this effort.
- The place of performance is Rockville, MD, United States.